← Browse by Condition
Medical Condition

bulimia nervosa

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for bulimia nervosa sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — bulimia nervosa Clinical Trials

How many clinical trials are currently recruiting for bulimia nervosa?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for bulimia nervosa, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for bulimia nervosa?
bulimia nervosa research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a bulimia nervosa clinical trial?
Eligibility criteria for bulimia nervosa trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Uppsala University Hospital 2 trials
University of North Carolina, Chapel Hill 1 trial

Recruiting Clinical Trials

NCT06592963
Recruiting
Unfolding Severe and Enduring Eating Disorders (U-SEED)
Enrollment
50 pts
Location
Sweden
Sponsor
Uppsala University Hospital
View Trial →
NCT06752304
Recruiting
A Longitudinal Study of Severe and Enduring Eating Disorders
Enrollment
800 pts
Location
Sweden
Sponsor
Uppsala University Hospital
View Trial →
NCT06594913
Recruiting
Eating Disorders Genetics Initiative 2
Enrollment
20,000 pts
Location
United States, Austr...
Sponsor
University of North Carolina, ...
View Trial →

Related Conditions

anorexia nervosa (3) binge eating disorder (3) eating disorders (2) personality disorders (1) other specified feeding or eating disorder (1) avoidant restrictive food intake disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology